CEO: Maria Fardis

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Iovance Biotherapeutics Inc is a biopharmaceutical company in the United States. Its lead pipeline candidate, LN-144, uses the tumor-infiltrating lymphocytes to treat serious diseases.


Key numbers

Market Capitalization:2869674300
Shares Outstanding: 126195000
Float: 114788612.535
Next Earning Date:2020-03-06
TTm EPS: -1.3567
TTm Dividend Rate:
200 days moving average:17.24
50 days moving average: 20.26
One day percent Change: 10.87



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,